Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05578053
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-10-13
First Post:
2022-10-10
Brief Title:
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-26
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-10
First Submit QC Date:
October 10 2022
Study First Post Date:
2022-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-10
Last Update Post Date:
2022-10-13
Last Update Post Date Type:
ACTUAL